Macromolecular permeability across the blood-nerve and blood-brain barriers.
Open accessAbstract
The permeability of insulin (Ins), nerve growth factor (NGF), albumin (Alb), transferrin (Trf), and IgG across the blood-nerve barrier (BNB) and blood-brain barrier (BBB) in normal adult rats was quantified by measuring the (permeability coefficient x surface area) product (PS) with the i.v. bolus-injection technique in the cannulated brachial vein and artery using radioiodinated proteins. The PS values of the BNB for IgG and Alb were low: 0.079 +/- 0.029 x 10(-6) and 0.101 +/- 0.088 x 10(-6) ml.g-1.s-1, (mean +/- SD, respectively). The PS values for NGF and Trf were 16.1-fold and 25.5-fold higher than for Alb. The PS for Ins across the BNB was 33.190 +/- 2.053 x 10(-6) ml.g-1.s-1--a remarkable 329-fold increase compared with Alb. The PS values of the BBB for IgG and Alb in different brain regions were all low, from 0.028 +/- 0.017 to 0.151 +/- 0.035 x 10(-6) ml.g-1.s-1 (mean +/- SD). NGF and Trf had comparable PS values from 13- to 32-fold higher than for Alb, except for the brain stem, where the PS for Trf was 66-fold higher than for Alb. The mean PS for Ins across the BBB ranged from 15.78 +/- 5.45 x 10(-6) ml.g-1.s-1 for the cortex to 22.62 +/- 7.50 x 10(-6) ml.g-1.s-1 for the brain stem--again a remarkable 105- to 390-fold increase relative to Alb. Because reliable PS measurements were obtained for all proteins tested, the BBB and BNB cannot be considered impermeable to proteins--a concept that has plagued brain- and nerve-barrier research. The low PS values for IgG and Alb indicate low rates of transfer; however, Alb, in particular, is the major protein of endoneurial and ventricular fluid, which suggests that these PS values may be significant. Ins had the highest PS values, which likely reflect the mechanism of transport across the barriers--that is, receptor-mediated transport. Because NGF and Trf had PS values 13- to 66-fold higher than for Alb, whether this reflects receptor-mediated uptake, adsorptive-mediated transcytosis, or some other mechanism is unclear. That the PS values for NGF and Trf differ from Alb and IgG clearly suggests, however, a different uptake mechanism. Finally, the remarkably high PS values for Ins across the BBB and BNB identify this protein and its putative receptor on capillary endothelial cells as a potential target for drug delivery into the central and peripheral nervous systems.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
mAbs exhibit limited distribution to the brain, with mAb concentrations determined to be 0.1-0.2% and 0.02% of the steady-state circulating mAb concentration in rodents and cynomolgus monkey, respectively.
“mAbs exhibit limited distribution to the brain, and mAb concentrations was determined to be 0.1–0.2 % and 0.02 % of the steady‐state circulating mAb concentration in rodents and cynomolgus monkey, respectively.92, 93”
From Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development (2018) · cites this paper as [92]
The PK of the anti-Her2/CD3 T cell-dependent bispecific (TDB) antibody in rats demonstrated similar clearance and half-life as trastuzumab.
“the PK of the anti‐Her2/CD3T cell‐dependent bispecific (TDB) antibody in rats demonstrated similar clearance and half‐life as trastuzumab.92”
From Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development (2018) · cites this paper as [92]
Cites
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482 · see citing works
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,565 · see citing works
Transferrin receptor on endothelium of brain capillaries
Jefferies, W. A., Brandon, M. R., Hunt, S. V., Williams, A. F., Gatter, K. C., & Mason, D. Y. (1984) · Nature · doi:10.1038/312162a0 · Cited by 1,061 · see citing works
Insulin in the Brain: A Hormonal Regulator of Energy Balance*
Schwartz, M. W., Figlewicz, D. P., Baskin, D. G., Woods, S. C., & Porte, D. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-3-387 · Cited by 808 · see citing works
An immunohistochemical study of the nerve growth factor receptor in developing rats
Yan, Q., & Johnson, E. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-09-03481.1988 · Cited by 605 · see citing works
Receptor‐mediated transcytosis of transferrin across the blood‐brain barrier
Fishman, J. B., Rubin, J. B., Handrahan, J. V., Connor, J. R., & Fine, R. E. (1987) · Journal of Neuroscience Research · doi:10.1002/jnr.490180206 · Cited by 545 · see citing works
Taniuchi, M., Clark, H., Schweitzer, J. B., & Johnson, E. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-02-00664.1988 · Cited by 542 · see citing works
Receptor-Mediated Transport of Insulin Across Endothelial Cells
King, G. L., & Johnson, S. M. (1985) · Science · doi:10.1126/science.3883490 · Cited by 474 · see citing works
Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat
Ohno, K., Pettigrew, K. D., & Рапопорт, С. И. (1978) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1978.235.3.h299 · Cited by 445 · see citing works
UNGER, J., Livingston, J. H., & Moss, A. (1991) · Progress in Neurobiology · doi:10.1016/0301-0082(91)90015-s · Cited by 403 · see citing works
Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.
Friden, P. M., Walus, L. R., Musso, G. F., Taylor, M. A., Malfroy, B., & Starzyk, R. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4771 · Cited by 402 · see citing works
Human Blood—Brain Barrier Insulin Receptor
Pardridge, W. M., Eisenberg, J., & Yang, J. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07167.x · Cited by 399 · see citing works
Weisiger, R. A., Gollan, J. L., & Ockner, R. K. (1981) · Science · doi:10.1126/science.6258226 · Cited by 383 · see citing works
Ghitescu, L. D., Fixman, A., Simionescu, M., & Simionescu, M. (1986) · The Journal of Cell Biology · doi:10.1083/jcb.102.4.1304 · Cited by 369 · see citing works
Blood-brain barrier transcytosis of insulin in developing rabbits
Duffy, K. R., & Pardridge, W. M. (1987) · Brain Research · doi:10.1016/0006-8993(87)90236-8 · Cited by 358 · see citing works
Pardridge, W. M., Buciak, J. L., & Friden, P. M. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20567-5 · Cited by 358 · see citing works
Human blood-brain barrier transferrin receptor
Pardridge, W. M., Eisenberg, J., & Yang, J. (1987) · Metabolism · doi:10.1016/0026-0495(87)90099-0 · Cited by 356 · see citing works
Kumagai, A. K., Eisenberg, J., & Pardridge, W. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48160-4 · Cited by 325 · see citing works
Simionescu, N., Simionescu, M., & Palade, G. E. (1981) · The Journal of Cell Biology · doi:10.1083/jcb.90.3.605 · Cited by 270 · see citing works
Transcytosis of albumin in capillary endothelium.
Milici, A. J., Watrous, N. E., Stukenbrok, H., & Palade, G. E. (1987) · The Journal of Cell Biology · doi:10.1083/jcb.105.6.2603 · Cited by 269 · see citing works
Рапопорт, С. И., Ohno, K., & Pettigrew, K. D. (1979) · Brain Research · doi:10.1016/0006-8993(79)90546-8 · Cited by 236 · see citing works
Pioro, E. P., & Cuello, A. C. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90304-m · Cited by 226 · see citing works
Methods for quantifying the transport of drugs across brain barrier systems
Fenstermacher, J. D., Blasberg, R. G., & Patlak, C. S. (1981) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(81)90062-0 · Cited by 214 · see citing works
Woolf, N. J., Gould, E. A., & Butcher, L. L. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90360-6 · Cited by 212 · see citing works
Triguero, D., Buciak, J. L., Yang, J., & Pardridge, W. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.12.4761 · Cited by 210 · see citing works
Receptor-mediated endocytosis of transferrin at the blood-brain barrier
ROBERTS, R. L., Fine, R. E., & Sandra, A. (1993) · Journal of Cell Science · doi:10.1242/jcs.104.2.521 · Cited by 205 · see citing works
Albumin helps mediate removal of taurocholate by rat liver.
Forker, E. L., & Luxon, B. A. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110182 · Cited by 195 · see citing works
Broadwell, R. D. (1989) · Acta Neuropathologica · doi:10.1007/bf00294368 · Cited by 172 · see citing works
Frank, H. J. L., Pardridge, W. M., Morris, W. L., Rosenfeld, R. G., & Choi, T. B. (1986) · Diabetes · doi:10.2337/diab.35.6.654 · Cited by 170 · see citing works
Localization of nerve growth factor receptor messenger RNA and protein in the adult rat brain
Koh, S., Oyler, G. A., & Higgins, G. A. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90154-4 · Cited by 168 · see citing works
Iron and transferrrin uptake by brain and cerebrospinal fluid in the rat
Crowe, A. P., & Morgan, E. H. (1992) · Brain Research · doi:10.1016/0006-8993(92)91652-u · Cited by 150 · see citing works
Pioro, E. P., & Cuello, A. C. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90305-n · Cited by 149 · see citing works
Yan, Q., & Johnson, E. M. (1989) · The Journal of Comparative Neurology · doi:10.1002/cne.902900411 · Cited by 148 · see citing works
Poduslo, J. F. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90463-2 · Cited by 124 · see citing works
Self-citationNerve growth factor receptors in the central nervous system
Springer, J. E. (1988) · Experimental Neurology · doi:10.1016/0014-4886(88)90231-2 · Cited by 105 · see citing works
The Mechanism of Action of Nerve Growth Factor
Levi, A., & Alemà, S. (1991) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.31.040191.001225 · Cited by 103 · see citing works
Transendothelial transport of serum albumin: a quantitative immunocytochemical study
Ghitescu, L. D., & Bendayan, M. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.117.4.745 · Cited by 103 · see citing works
Villegas, J. C., & Broadwell, R. D. (1993) · Journal of Neurocytology · doi:10.1007/bf01181571 · Cited by 101 · see citing works
Carrier‐mediated transport of vasorpressin across the blood‐brain barrier of the mouse
Banks, W. A., Kastin, A. J., Horváth, A., & Michals, E. A. (1987) · Journal of Neuroscience Research · doi:10.1002/jnr.490180209 · Cited by 100 · see citing works
Bjerre, B., Björklund, A., Mobley, W. C., & Rosengren, E. (1975) · Brain Research · doi:10.1016/0006-8993(75)90061-x · Cited by 91 · see citing works
Smith, K. R., & Borchardt, R. T. (1989) · Pharmaceutical Research · doi:10.1023/a:1015960205409 · Cited by 90 · see citing works
Raub, T. J., & Newton, C. R. (1991) · Journal of Cellular Physiology · doi:10.1002/jcp.1041490118 · Cited by 89 · see citing works
Stremmel, W., Potter, B. J., & Berk, P. D. (1983) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(83)90019-3 · Cited by 84 · see citing works
Absence of albumin receptor on brain capillaries in vivo or in vitro
Pardridge, W. M., Eisenberg, J., & Cefalu, W. T. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.249.3.e264 · Cited by 82 · see citing works
Seitz, R. J., Heininger, K., Schwendemann, G., Toyka, K. V., & Wechsler, W. (1985) · Acta Neuropathologica · doi:10.1007/bf00688950 · Cited by 81 · see citing works
A brain-to-blood carrier-mediated transport system for small, N-Tyrosinated peptides
Banks, W. A., & Kastin, A. J. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(84)80077-5 · Cited by 79 · see citing works
Chimeric peptides as a vehicle for peptide pharmaceutical delivery through the blood-brain barrier
Pardridge, W. M., Kumagai, A. K., & Eisenberg, J. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90726-1 · Cited by 78 · see citing works
Increase in albumin, IgG, and IgM blood-nerve barrier indices in human diabetic neuropathy.
Poduslo, J. F., Curran, G. L., & Dyck, P. J. B. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4879 · Cited by 72 · see citing works
Self-citationTransport of histone through the blood-brain barrier.
Pardridge, W. M., Triguero, D., & Buciak, J. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21084-9 · Cited by 69 · see citing works
Zloković, B. V., Skundric, D. S., Segal, M. B., Lipovac, M. N., Mačkić, J. B., & Davson, H. (1990) · Experimental Neurology · doi:10.1016/0014-4886(90)90144-h · Cited by 68 · see citing works
Poduslo, J. F., & Curran, G. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2218 · Cited by 68 · see citing works
Self-citationAltar, C. A., Burton, L. E., Bennett, G. L., & Dugich‐Djordjevic, M. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.281 · Cited by 67 · see citing works
Banks, W. A., Kastin, A. J., & Fasold, M. B. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24453-6 · Cited by 66 · see citing works
Rosenfeld, R. G., Pham, H. M., Keller, B. T., BORCHARDT, R. T., & Pardridge, W. M. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)91618-4 · Cited by 65 · see citing works
Banks, W. A., Audus, K. L., & Davis, T. P. (1992) · Peptides · doi:10.1016/0196-9781(92)90037-4 · Cited by 63 · see citing works
Selective accumulation of [125I] labelled nerve growth factor in sympathetic ganglia
Angeletti, R. H., Angeletti, P. U., & Levi‐Montalcini, R. (1972) · Brain Research · doi:10.1016/0006-8993(72)90033-9 · Cited by 61 · see citing works
Chronic nerve growth factor treatment of normotensive rats
Zettler, C., Head, R. J., & Rush, R. A. (1991) · Brain Research · doi:10.1016/0006-8993(91)90437-z · Cited by 58 · see citing works
Delivering Peptides to the Central Nervous System: Dilemmas and Strategies
Banks, W. A., Kastin, A. J., & Barrera, C. M. (1991) · Pharmaceutical Research · doi:10.1023/a:1015884603456 · Cited by 54 · see citing works
D-[Ala1]-peptide T-Amide is transported from blood to brain by a saturable system
Barrera, C. M., Kastin, A. J., & Banks, W. A. (1987) · Brain Research Bulletin · doi:10.1016/0361-9230(87)90048-7 · Cited by 54 · see citing works
Expression of nerve growth factor receptor in paraffin-embedded soft tissue tumors.
Perosio, P. M., & Brooks, J. J. (1988) · PubMed · Cited by 51 · see citing works
Vascular transport of insulin to rat cardiac muscle. Central role of the capillary endothelium.
Bar, R. S., Boes, M. K., & Sandra, A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113439 · Cited by 50 · see citing works
Specific binding of atrial natriuretic factor in brain microvessels.
Chabrier, P. E., Roubert, P., & Braquet, P. G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.2078 · Cited by 49 · see citing works
Bernd, P., Martínez, H., Dreyfus, C. F., & Black, I. B. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90131-5 · Cited by 35 · see citing works
Mammalian endoneurial fluid: Collection and protein analysis from normal and crushed nerves
Poduslo, J. F., Low, P. A., Nickander, K. K., & Dyck, P. J. B. (1985) · Brain Research · doi:10.1016/0006-8993(85)90392-0 · Cited by 35 · see citing works
Self-citationBruyn, P. P. H. D., Michelson, S., & Bankston, P. W. (1985) · Cell and Tissue Research · doi:10.1007/bf00217551 · Cited by 34 · see citing works
Blood-nerve transfer of albumin and its implications for the endoneurial microenvironment
Weerasuriya, A., Curran, G. L., & Poduslo, J. F. (1989) · Brain Research · doi:10.1016/0006-8993(89)90149-2 · Cited by 33 · see citing works
Self-citationMIF-1 antagonizes warm-, but not cold-water stress-induced analgesia: Dissociation from immobility
Galina, Z. H., & Kastin, A. J. (1985) · Peptides · doi:10.1016/0196-9781(85)90435-8 · Cited by 33 · see citing works
Stereospecific transport of Tyr-MIF-1 across the blood-brain barrier by peptide transport system-1
Banks, W. A., Kastin, A. J., Michals, E. A., & Barrera, C. M. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90116-h · Cited by 32 · see citing works
Smith, K. R., Kato, A., & Borchardt, R. T. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80048-2 · Cited by 31 · see citing works
Fried, K., Risling, M., Arvidsson, U., & Paulie, S. (1990) · Brain Research · doi:10.1016/0006-8993(90)90043-b · Cited by 27 · see citing works
Poduslo, J. F., Low, P. A., Aj, W., Dyck, P., Berg, C., & Schmelzer, J. (1982) · Journal of Neuroscience · doi:10.1523/jneurosci.02-10-01507.1982 · Cited by 26 · see citing works
Self-citationVORBRODT, A. W., & Trowbridge, R. S. (1991) · Journal of Neurocytology · doi:10.1007/bf01187917 · Cited by 24 · see citing works
Endocytosis of formaldehyde-denatured serum albumin by nonparenchymal liver cells in vitro
Eskild, W., & Berg, T. (1984) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(84)90055-7 · Cited by 24 · see citing works
Drug transport across the blood-brain barrier
van Bree, J. B. M. M., de Boer, A. G., Danhof, M., & Breimer, D. D. (1993) · Pharmacy World & Science · doi:10.1007/bf02116163 · Cited by 22 · see citing works
New role of nerve growth factor — an inhibitory neuromodulator of adrenergic transmission
Ueyama, T., Hano, T., Hamada, M., Nishio, I., & Masuyama, Y. (1991) · Brain Research · doi:10.1016/0006-8993(91)90014-m · Cited by 21 · see citing works
Nerve growth factor receptor immunoreactivity in human benign peripheral nerve sheath tumor
Yasuda, T., Sobue, G., Mitsuma, T., Takahashi, A., & Hashizume, Y. (1989) · Acta Neuropathologica · doi:10.1007/bf00687886 · Cited by 21 · see citing works
Drug transport across the blood — brain barrier
van Bree, J. B. M. M., Boer, A. G. D., Danhof, M., & Breimer, D. D. (1992) · Pharmacy World & Science · doi:10.1007/bf01970169 · Cited by 21 · see citing works
Regional blood-brain barrier transport of cationized bovine serum albumin in awake rats
Shimon‐Hophy, M., Wadhwani, K. C., Chandrasekaran, K., Larson, D. M., Smith, Q. R., & Рапопорт, С. И. (1991) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1991.261.2.r478 · Cited by 19 · see citing works
Saturable transport of manganese(II) across blood-nerve barrier of rat peripheral nerve
Wadhwani, K. C., Murphy, V. A., Smith, Q. R., & Рапопорт, С. И. (1992) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1992.262.2.r284 · Cited by 18 · see citing works
Are genetically hypertensive rats deficient in nerve growth factor?
Messina, A., & Bell, C. (1991) · Neuroreport · doi:10.1097/00001756-199101000-00011 · Cited by 15 · see citing works
Nerve growth factor receptor immunoreactivity in non-nervous structures of the adult rat brain.
del Valle, M. E., Alvarez-Mendez, J. C., Calzada, B., & Ja, V. (1992) · PubMed · Cited by 5 · see citing works
Flagged first, then by citations
1 of the 82 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity
Kadry, H., Noorani, B., & Cucullo, L. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00230-3 · Cited by 1,853 · see citing works
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402 · see citing works
Current Challenges and Opportunities in Treating Glioblastoma
Shergalis, A. G., Bankhead, A., Luesakul, U., Muangsin, N., & Neamati, N. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014944 · Cited by 847 · see citing works
Circulating Insulin-Like Growth Factor I Mediates Effects of Exercise on the Brain
Carro, E., Nuñez, A., Busiguina, S., & Torres-Aleman, I. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-08-02926.2000 · Cited by 762 · see citing works
The blood–brain barrier in health and disease: Important unanswered questions
Profaci, C. P., Munji, R. N., Pulido, R. S., & Daneman, R. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190062 · Cited by 781 · see citing works
Beyond Neurons: Evidence That Immune and Glial Cells Contribute to Pathological Pain States
Watkins, L. R., & Maier, S. F. (2002) · Physiological Reviews · doi:10.1152/physrev.00011.2002 · Cited by 733 · see citing works
CNS Delivery Via Adsorptive Transcytosis
Hervé, F., Ghinea, N., & Scherrmann, J.-M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9055-2 · Cited by 676 · see citing works
Niewoehner, J., Bohrmann, B., Collin, L., Urich, E., Sade, H., Maier, P., Rueger, P., Stracke, J. O., Lau, W., Tissot, A. C., et al. (2014) · Neuron · doi:10.1016/j.neuron.2013.10.061 · Cited by 622 · see citing works
Poduslo, J. F., & Curran, G. L. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00250-v · Cited by 614 · see citing works
Self-citationCampylobacter Species and Guillain-Barre Syndrome
Nachamkin, I., Allos, B. M., & Ho, T. W. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.555 · Cited by 591 · see citing works
Insulin in the brain: There and back again
Banks, W. A., Owen, J. B., & Erickson, M. A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.006 · Cited by 576 · see citing works
Physiological blood–brain transport is impaired with age by a shift in transcytosis
Yang, A. C., Stevens, M. Y., Chen, M. B., Lee, D. P., Stähli, D., Gate, D., Contrepois, K., Chen, W., Iram, T., Zhang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2453-z · Cited by 477 · see citing works
Binding of transition metal ions to albumin: Sites, affinities and rates
Bal, W., Sokołowska, M., Kurowska, E., & Faller, P. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.06.018 · Cited by 495 · see citing works
Delivery of Neurotrophic Factors to the Central Nervous System: Pharmacokinetic Considerations
Thorne, R. G., & Frey, W. H. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140120-00003 · Cited by 487 · see citing works
Bohrmann, B., Baumann, K., Benz, J., Gerber, F., Huber, W., Knoflach, F., Messer, J., Oroszlan, K., Rauchenberger, R., Richter, W. F., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110977 · Cited by 448 · see citing works
Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy
Zheng, Q., & Wang, X. (2024) · Protein & Cell · doi:10.1093/procel/pwae026 · Cited by 454 · see citing works
Marsh, S. E., Abud, E. M., Lakatos, A., Karimzadeh, A., Yeung, S. T., Davtyan, H., Fote, G. M., Lau, L., Weinger, J. G., Lane, T. E., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525466113 · Cited by 411 · see citing works
Kariolis, M. S., Wells, R. C., Getz, J. A., Kwan, W., Mahon, C. S., Tong, R. K., Kim, D. J., Srivastava, A., Bédard, C., Henne, K. R., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay1359 · Cited by 355 · see citing works
Matrices and scaffolds for protein delivery in tissue engineering
Teßmar, J., & Göpferich, A. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.020 · Cited by 346 · see citing works
Zlokovic, B. V., Martel, C. L., Matsubara, E., McComb, J. G., Zheng, G., McCluskey, R. T., Frangione, B., & Ghiso, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4229 · Cited by 430 · see citing works
Pardridge, W. M., Kang, Y., Buciak, J. L., & Yang, J. (1995) · Pharmaceutical Research · doi:10.1023/a:1016244500596 · Cited by 317 · see citing works
Improving influence of insulin on cognitive functions in humans
Kern, W., Peters, A., Fruehwald-Schultes, B., Deininger, E., Born, J., & Fehm, H. L. (2001) · Neuroendocrinology · doi:10.1159/000054694 · Cited by 308 · see citing works
Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development
Ovacik, M., & Lin, K. (2018) · Clinical and Translational Science · doi:10.1111/cts.12567 · Cited by 299 · see citing works
Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies
Zuchero, Y. J. Y., Chen, X., Bien‐Ly, N., Bumbaca, D., Tong, R. K., Gao, X., Zhang, S., Hoyte, K., Luk, W., Huntley, M. A., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.11.024 · Cited by 283 · see citing works
Raivich, G., Jones, L. L., Kloss, C. U. A., Werner, A., Neumann, H., & Kreutzberg, G. W. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-15-05804.1998 · Cited by 273 · see citing works
Yoo, S. I., Yang, M., Brender, J., Vivekanandan, S., Sun, K., Joo, N. E., Jeong, S., Ramamoorthy, A., & Kotov, N. A. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007824 · Cited by 268 · see citing works
Multispecific drugs herald a new era of biopharmaceutical innovation
Deshaies, R. J. (2020) · Nature · doi:10.1038/s41586-020-2168-1 · Cited by 262 · see citing works
Kutuzov, N. P., Flyvbjerg, H., & Lauritzen, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802155115 · Cited by 243 · see citing works
Peptide and Protein Mimetics Inhibiting Amyloid β-Peptide Aggregation
Takahashi, T., & Mihara, H. (2008) · Accounts of Chemical Research · doi:10.1021/ar8000475 · Cited by 237 · see citing works
Wiping Out CGRP: Potential Cardiovascular Risks
MaassenVanDenBrink, A., Meijer, J., Villalón, C. M., & Ferrari, M. D. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.06.002 · Cited by 231 · see citing works
Developing Therapeutic Antibodies for Neurodegenerative Disease
Yu, Y. J., & Watts, R. J. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0187-4 · Cited by 227 · see citing works
Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer’s disease
Sehlin, D., Fang, X. T., Cato, L., Antoni, G., Lannfelt, L., & Syvänen, S. (2016) · Nature Communications · doi:10.1038/ncomms10759 · Cited by 223 · see citing works
Occlusion and brain function: mastication as a prevention of cognitive dysfunction
Ono, Y., YAMAMOTO, T., Kubo, K., & Onozuka, M. (2010) · Journal of Oral Rehabilitation · doi:10.1111/j.1365-2842.2010.02079.x · Cited by 226 · see citing works
Peripheral immune system in aging and Alzheimer’s disease
Cao, W., & Zheng, H. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0284-2 · Cited by 214 · see citing works
Jarius, S., Franciotta, D. M., Paul, F., Ruprecht, K., Bergamaschi, R., Rommer, P. S., Reuß, R., Probst, C., Kristoferitsch, W., Wandinger, K., et al. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-52 · Cited by 208 · see citing works
Li, H., Luo, Y., Derreumaux, P., & Wei, G. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.09.046 · Cited by 190 · see citing works
Targeting microglia for the treatment of Alzheimer’s Disease
Wes, P. D., Sayed, F. A., Bard, F., & Gan, L. (2016) · Glia · doi:10.1002/glia.22988 · Cited by 185 · see citing works
Endocytosis at the blood–brain barrier: From basic understanding to drug delivery strategies
Smith, M. W., & Gumbleton, M. (2006) · Journal of drug targeting · doi:10.1080/10611860600650086 · Cited by 185 · see citing works
Wilton, D. K., Mastro, K. J., Heller, M. D., Gergits, F. W., Willing, C. R., Fahey, J. B., Frouin, A., Daggett, A., Gu, X., Kim, Y. A., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02566-3 · Cited by 179 · see citing works
Biology of the blood–nerve barrier and its alteration in immune mediated neuropathies
Kanda, T. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302312 · Cited by 175 · see citing works
Shimizu, F., Sano, Y., Abe, M., Maeda, T., Ohtsuki, S., Terasaki, T., & Kanda, T. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22337 · Cited by 163 · see citing works
Graphene quantum dots for the inhibition of β amyloid aggregation
Liu, Y., Xu, L., Dai, W., Dong, H., Wen, Y., & Zhang, X. (2015) · Nanoscale · doi:10.1039/c5nr06282a · Cited by 162 · see citing works
New roles for Fc receptors in neurodegeneration-the impact on Immunotherapy for Alzheimer's Disease
Fuller, J. P., Stavenhagen, J. B., & Teeling, J. L. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00235 · Cited by 154 · see citing works
Impaired blood–brain and blood–spinal cord barriers in mutant SOD1-linked ALS rat
Nicaise, C., Mitrecic, D., Demetter, P., De Decker, R., Authelet, M., Boom, A., & Pochet, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.018 · Cited by 168 · see citing works
Sheppard, O., Coleman, M. P., & Durrant, C. S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1490-8 · Cited by 149 · see citing works
Peptides crossing the blood–brain barrier: some unusual observations
Kastin, A. J., Pan, W., Maness, L. M., & Banks, W. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01961-7 · Cited by 144 · see citing works
Antibody therapies in CNS diseases
Freskgård, P., & Urich, E. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.014 · Cited by 139 · see citing works
Shimizu, F., Sano, Y., Saito, K., Abe, M., Maeda, T., Haruki, H., & Kanda, T. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0626-8 · Cited by 144 · see citing works
The Neurovascular Unit Dysfunction in Alzheimer’s Disease
Soto-Rojas, L. O., Pacheco‐Herrero, M., Martínez-Gómez, P. A., Campa-Córdoba, B. B., Apátiga-Pérez, R., Villegas-Rojas, M. M., Harrington, C. R., de la Cruz, F., Garcés‐Ramírez, L., & Luna‐Muñoz, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042022 · Cited by 140 · see citing works
Neurodegeneration Is Associated to Changes in Serum Insulin-like Growth Factors
Busiguina, S., Fernandez, A. M., Barrios, V., Clark, R., Tolbert, D. L., Berciano, J., & Torres‐Alemán, I. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0311 · Cited by 137 · see citing works
Zloković, B. V. (1995) · Pharmaceutical Research · doi:10.1023/a:1016254514167 · Cited by 131 · see citing works
Zhang, P., Hu, L., Yin, Q., Feng, L., & Li, Y. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200600t · Cited by 129 · see citing works
Cleek, R. L., Ting, K. C., Eskin, S. G., & Mikos, A. G. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00052-7 · Cited by 124 · see citing works
Brain Repair and Neuroprotection by Serum Insulin-Like Growth Factor I
Carro, E., Trejo, J. L., Núñez, Á., & Torres‐Alemán, I. (2003) · Molecular Neurobiology · doi:10.1385/mn:27:2:153 · Cited by 122 · see citing works
Efflux of monoclonal antibodies from rat brain by neonatal Fc receptor, FcRn
Cooper, P. R., Ciambrone, G. J., Kliwinski, C. M., Maze, E., Johnson, L., Li, Q., Feng, Y., & Hornby, P. J. (2013) · Brain Research · doi:10.1016/j.brainres.2013.08.035 · Cited by 121 · see citing works
CD33 in Alzheimer’s Disease – Biology, Pathogenesis, and Therapeutics: A Mini-Review
Zhao, L. (2018) · Gerontology · doi:10.1159/000492596 · Cited by 124 · see citing works
Poduslo, J., Curran, G., Wengenack, T. M., Malester, B., & Duff, K. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0402 · Cited by 111 · see citing works
Self-citationImmune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
Pearson, J. R. D., Cuzzubbo, S., McArthur, S., Durrant, L. G., Adhikaree, J., Tinsley, C. J., Pockley, A. G., & McArdle, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.582106 · Cited by 118 · see citing works
Körner, H., Lemckert, F. A., Chaudhri, G., Etteldorf, S., & Sedgwick, J. D. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270822 · Cited by 117 · see citing works
Stanislaus, S., Hecht, R. I., Yie, J., Hager, T., Hall, M. P., Spahr, C. S., Wang, W., Weiszmann, J., Li, Y., Deng, L., et al. (2017) · Endocrinology · doi:10.1210/en.2016-1917 · Cited by 116 · see citing works
Near nerve local insulin prevents conduction slowing in experimental diabetes
Singhal, A., Cheng, C., Sun, H., & Zochodne, D. W. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00412-5 · Cited by 114 · see citing works
Poduslo, J. F., Curran, G. L., Kumar, A. R., Frangione, B., & Soto, C. A. (1999) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(19990605)39:3 · Cited by 114 · see citing works
Self-citationShimizu, F., Sano, Y., Tominaga, O., Maeda, T., Abe, M., & Kanda, T. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.012 · Cited by 106 · see citing works
Progressive supranuclear palsy: Advances in diagnosis and management
Coughlin, D. G., & Litvan, I. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.04.014 · Cited by 113 · see citing works
Ho, T. W., McKhann, G. M., & Griffin, J. W. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.187 · Cited by 107 · see citing works
Saltzman, W. M., Mak, M., Mahoney, M. J., Duenas, E. T., & Cleland, J. L. (1999) · Pharmaceutical Research · doi:10.1023/a:1018824324275 · Cited by 106 · see citing works
Impairment of the Blood–Nerve and Blood–Brain Barriers in Apolipoprotein E Knockout Mice
Fullerton, S. M., Shirman, G. A., Strittmatter, W. J., & Matthew, W. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7631 · Cited by 117 · see citing works
Banks, W. A., Farr, S. A., Morley, J. E., Wolf, K. M., Geylis, V., & Steinitz, M. O. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.005 · Cited by 103 · see citing works
Serum Growth Factors and Neuroprotective Surveillance
Torres‐Alemán, I. (2000) · Molecular Neurobiology · doi:10.1385/mn:21:3:153 · Cited by 104 · see citing works
Biology of the human blood-nerve barrier in health and disease
Ubogu, E. E. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113272 · Cited by 102 · see citing works
Immunotherapy for Alzheimer's disease
Dodel, R. C., Hampel, H. J., & Du, Y. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00349-1 · Cited by 102 · see citing works
Mukherjee, S., Fried, A., Hussaini, R., White, R., Baidoo, J., Yalamanchi, S., & Banerjee, P. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0792-5 · Cited by 100 · see citing works
Shimizu, F., Sano, Y., Haruki, H., & Kanda, T. (2011) · Diabetologia · doi:10.1007/s00125-011-2107-7 · Cited by 100 · see citing works
Transport and elimination of recombinant human NGF during long-term delivery to the brain
Krewson, C. E., & Saltzman, W. M. (1996) · Brain Research · doi:10.1016/0006-8993(96)00378-2 · Cited by 99 · see citing works
CD98hc is a target for brain delivery of biotherapeutics
Chew, K. S., Wells, R. C., Moshkforoush, A., Chan, D., Lechtenberg, K. J., Tran, H. L., Chow, J., Kim, D. J., Robles‐Colmenares, Y., Srivastava, D. B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40681-4 · Cited by 98 · see citing works
Lampe, K. J., Kern, D. S., Mahoney, M. J., & Bjugstad, K. B. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.33011 · Cited by 98 · see citing works
Engineered antibodies: new possibilities for brain PET?
Sehlin, D., & Syvänen, S. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04426-0 · Cited by 96 · see citing works
Kumar, N. N., Lochhead, J. J., Pizzo, M. E., Nehra, G., Boroumand, S., Greene, G., & Thorne, R. G. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.006 · Cited by 95 · see citing works
Towards Non Invasive Nerve Growth Factor Therapies for Alzheimer's Disease
Cattaneo, A., Capsoni, S., & Paoletti, F. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15210 · Cited by 94 · see citing works
Perrone, L., Mothes-Martin, E., Vignes, M., Mockel, A., Figueroa, C. M., Miquel, M., Maddelein, M., & Faller, P. (2009) · ChemBioChem · doi:10.1002/cbic.200900474 · Cited by 89 · see citing works
Molecular architecture determines brain delivery of a transferrin receptor–targeted lysosomal enzyme
Arguello, A., Mahon, C. S., Calvert, M., Chan, D., Dugas, J. C., Pizzo, M. E., Thomsen, E. R., Chau, R., Damo, L. A., Duque, J. N., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20211057 · Cited by 89 · see citing works
Poduslo, J. F., Ramakrishnan, M., Holasek, S. S., Ramı́rez-Alvarado, M., Kandimalla, K. K., Gilles, E. J., Curran, G. L., & Wengenack, T. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04591.x · Cited by 89 · see citing works
Self-citationTargeting Alzheimer amyloid plaques in vivo
Wengenack, T. M., Curran, G. L., & Poduslo, J. F. (2000) · Nature Biotechnology · doi:10.1038/78482 · Cited by 88 · see citing works
Self-citationFernandez, A. M., de la Vega, A. G., Planas, B., & Torres‐Alemán, I. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00623.x · Cited by 86 · see citing works
Receptor-Mediated Transport of Human Amyloid β-Protein 1–40 and 1–42 at the Blood–Brain Barrier
Poduslo, J. F., Curran, G. L., Sanyal, B., & Selkoe, D. J. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0238 · Cited by 83 · see citing works
Self-citationInsulin rescues amyloid β-induced impairment of hippocampal long-term potentiation
Lee, C.-C., Kuo, Y.-M., Huang, C.-C., & Hsu, K.-S. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.014 · Cited by 81 · see citing works
Identification and in vivo characterization of a brain-penetrating nanobody
Wouters, Y., Jaspers, T., Strooper, B. D., & Dewilde, M. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00226-z · Cited by 80 · see citing works
Poduslo, J. F., Curran, G. L., Peterson, J. A., McCormick, D., Fauq, A. H., Khan, M. A., & Wengenack, T. M. (2004) · Biochemistry · doi:10.1021/bi0359574 · Cited by 79 · see citing works
Self-citationHigh detection sensitivity with antibody-based PET radioligand for amyloid beta in brain
Fang, X. T., Hultqvist, G., Meier, S. R., Antoni, G., Sehlin, D., & Syvänen, S. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.10.011 · Cited by 76 · see citing works
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
Pitiot, A., Heuzé‐Vourc'h, N., & Sécher, T. (2022) · Antibodies · doi:10.3390/antib11030056 · Cited by 77 · see citing works
Ramakrishnan, M., Kandimalla, K. K., Wengenack, T. M., Howell, K. G., & Poduslo, J. F. (2009) · Biochemistry · doi:10.1021/bi900523q · Cited by 75 · see citing works
Self-citationCapsoni, S., Marinelli, S., Ceci, M., Vignone, D., Amato, G., Malerba, F., Paoletti, F., Meli, G., Viegi, A., Pavone, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037555 · Cited by 74 · see citing works
More Than Mortar: Glia as Architects of Nervous System Development and Disease
Lago‐Baldaia, I., Fernandes, V. M., & Ackerman, S. D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.611269 · Cited by 68 · see citing works
Engineering antibody and protein therapeutics to cross the blood–brain barrier
Zhao, P., Zhang, N., & An, Z. (2022) · Antibody Therapeutics · doi:10.1093/abt/tbac028 · Cited by 71 · see citing works
EGFRvIII: An Oncogene with Ambiguous Role
Rutkowska, A., Stoczyńska-Fidelus, E., Janik, K., Włodarczyk, A., & Rieske, P. (2019) · Journal of Oncology · doi:10.1155/2019/1092587 · Cited by 70 · see citing works
The Molecular and Biophysical Characterization of the Human Blood-Nerve Barrier: Current Concepts
Ubogu, E. E. (2013) · Journal of Vascular Research · doi:10.1159/000353293 · Cited by 69 · see citing works
Pornnoppadol, G., Bond, L. G., Lucas, M. J., Zupancic, J. M., Kuo, Y., Zhang, B., Greineder, C. F., & Tessier, P. M. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.09.008 · Cited by 70 · see citing works
Weidle, U. H., Niewöhner, J., & Tiefenthaler, G. (2015) · PubMed · Cited by 68 · see citing works
Pathophysiological Changes of Physical Barriers of Peripheral Nerves After Injury
Liu, Q., Wang, X., & Yi, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00597 · Cited by 67 · see citing works
Jungner, M., Grände, P., Mattiasson, G., & Bentzer, P. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181d94d6e · Cited by 67 · see citing works
- Authors
- Poduslo, J. F., Curran, G. L., & Berg, C. T.
- Affiliations
- Mayo Clinic (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1994-06-07
- Volume
- 91
- Issue
- 12
- Pages
- 5705-5709
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC44065
- OpenAlex
- W2071079524
- Cited by
- 377
- References
- 82
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 18 · 2023: 24 · 2022: 16 · 2021: 16 · 2020: 32 · 2019: 16 · 2018: 20 · 2017: 16 · 2016: 14 · 2015: 10 · 2014: 9 · 2013: 12 · 2012: 19
- FWCI
- 6.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Cerebrospinal fluid and hydrocephalus
- Keywords
- blood-nerve barrier, blood-brain barrier, macromolecule permeability, protein permeability, insulin, nerve growth factor, transferrin, IgG, albumin, permeability coefficient, brain regions, brainstem, ventricular fluid, radioiodinated proteins, rats
- MeSH terms
- Albumins, Animals, Blood-Brain Barrier, Brain, Endocytosis, Insulin, Male, Metabolic Clearance Rate, Nerve Growth Factors, Permeability, Transferrin, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review